Therapeutic monoclonal antibodies (mAbs) have become a dominant product class within the biopharmaceutical market. To date, therapeutic...
Key considerations for biologics CDMO tech transfer
A technology transfer (or CDMO tech transfer) consists in transferring process knowledge from development to manufacturing or between...
What are monoclonal antibodies and their therapeutic applications?
Monoclonal antibodies (mAbs) constitute a significant achievement in pharmacology over the past three decades. Here are some answers to...
From a project management perspective, what does it mean to be a full-service CDMO?
Discover our project management approach as a CDMO. GTP Bioways is an experienced CDMO (contract development and manufacturing...
Is your commercial HCP ELISA assay suitable to secure your bioprocess?
In early stages of biotherapeutic development, generic HCP ELISA are an easy-to-use solution to quantify HCP content in DS and show HCP...
COVID-19 vaccine race
Basic information about the COVID-19 vaccines based on World Health Organization data (available here). There are four main approaches to...
How to make gene optimization for expression in Escherichia coli a piece of cake
What you will read about: our opinion about gene optimization in E.coli. The redesign of coding sequences using predetermined parameters...
Biotherapeutic development: how we optimized CHO transient transfection for protein and antibody production
In order to provide timely production of your recombinant proteins and monoclonal antibodies, the GTP team has developed CHO-based...